CEimpact Podcast
The CEimpact Podcast features two shows:
GameChangers Clinical Updates
Precept2Practice
GameChangers Clinical Update Series:
The GameChangers podcast, hosted by Rachel Maynard, PharmD, features the latest game-changing pharmacotherapy advances impacting patient care. New episodes arrive every Monday. Listeners can purchase the episode to earn CE credit at: https://www.ceimpact.com/resources/podcast/
Precept2Practice
The Precept2Practice podcast, hosted by Kathy Schott, brings you tools to mentor students and residents with confidence. New episodes arrive on the third Wednesday of every month. Preceptor By Design™ subscribers can earn CE credit for each episode.
Give us a follow, tune in regularly, and turn your drive time, coffee break, or chart review into a chance to level up your practice. CEimpact continuing education makes pharmacy learning inspiring!
Check back each week for our latest episodes.
CEimpact Podcast
The 101 on Oral Therapies for COVID-19
Two oral therapies for COVID-19 were recently approved. Listen in as we discuss who is eligible to receive them, their efficacy, and what this means for the future of COVID-19 treatment.
Guest:
Patrick Kinn, PharmD, MPH, BCPS
Clinical Pharmacy Specialist - Infectious Disease
University of Iowa Health Care
John A. Galdo, PharmD, MBA, BCPS, BCGP (Jake)
Course Content and Developer, CEimpact
Pharmacist, Ross Bridge Pharmacy
CEO, Seguridad, Inc
Redeem your CPE or CME credit here!
Pharmacist members
CME
Need a membership?
Join for CPE Credit
Join for CME Credit
References and resources:
- Jayk BA, Gomes da Silva MM, Musungaie DB, et al. MOVe-OUT Study Group. Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients. N Engl J Med. 2021 Dec 16:NEJMoa2116044. doi: 10.1056/NEJMoa2116044. Epub ahead of print. PMID: 34914868; PMCID: PMC8693688.
- PAXLOVID (nirmatrelvir) [Emergency Use Authorization]. U.S. Food and Drug Administration website. Published December 22, 2021. Accessed January 5, 2021. https://www.fda.gov/media/155050/download
- Liverpool COVID-19 Interactions. https://www.covid19-druginteractions.org/
- COVID-19 Public Therapeutic Locator. https://healthdata.gov/Health/COVID-19-Public-Therapeutic-Locator/rxn6-qnx8/data
Continuing Education Information:
Learning Objectives:
- Identify the eligible population for treatment of COVID-19 with oral therapy
- Discuss the efficacy of currently available oral therapy treatment options for COVID-19
Dr. Wall is a member of the Janssen Speaker's Bureau.
Dr. Galdo reports no actual or potential conflicts of interest associated with this episode.
Dr. Kinn reports no actual or potential conflicts of interest associated with this episode.
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-056-H01-P
Initial release date: 01/17/22
Expiration date: 01/17/2023
Additional CPE & CME details can be found here